Evaluation of treatments with radiotherapy alone and radiotherapy plus chemo-immunotherapy in patients with primary liver cancer based on blood biomarkers.
Shi-Gao HuangYutian YinJianping LiMei ShiHuijie BianLina ZhaoPublished in: Current medicinal chemistry (2023)
Our evaluation of blood biomarkers before and after radiotherapy or plus chem-immunotherapy for primary liver cancer revealed a potential marker for clinics to decide on precise treatment strategies.